MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jir380

Медицинская библиотека · The Journal of infectious diseases · 2012

Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?

Gompels Mark, Dunn David T, Phillips Andrew, Dooley Debbie, De Burgh Thomas Andrew, Anderson Jane, Post Frank, Pillay Deenan, Gazzard Brian, Hill Teresa, Johnson Margaret, Gilson Richard, Bansi Loveleen, Easterbrook Philippa, Fisher Martin, Walsh John, Orkin Chloe, Ainsworth Jonathan, Leen Clifford, Sabin Caroline, UK Collaborative HIV Cohort (UK CHIC) Study (Appendix)

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

The CD4 count and CD4 percentage (CD4%) are both strong predictors of clinical disease progression in human immunodeficiency virus (HIV). Although individuals may show discordancy between their CD4 count and CD4%, the clinical relevance of this is unclear.

METHODS

Discordancy was defined where the CD4% was ≤10th percentile for a selected CD4 count range (referred to as low discordancy), within the central 80% range (concordant), or ≥90th percentile (high discordancy). Regression methods identified factors associated with low and high discordancy in untreated individuals and assessed the impact of discordancy on treatment responses to highly active antiretroviral therapy (HAART).

RESULTS

High discordancy was associated with female sex, low viral load, and white ethnicity; low discordancy was associated with black or nonwhite ethnicity, older age, and injection drug use. Clinical event rates were higher in individuals with high discordancy starting HAART, but there was no association with subsequent HIV progression by 6 months after starting HAART. CD4 count increases remained lower, by 20 cells/mm(3), in individuals with low discordancy, and higher, by 27 cells/mm(3), in those with high discordancy.

CONCLUSIONS

Overall discrepancies between the CD4/CD4% are small, confirming the use of absolute CD4 counts as a monitoring tool.

Для цитирования: Gompels Mark, Dunn David T, Phillips Andrew, Dooley Debbie, De Burgh Thomas Andrew, Anderson Jane, Post Frank, Pillay Deenan, Gazzard Brian, Hill Teresa, Johnson Margaret, Gilson Richard, Bansi Loveleen, Easterbrook Philippa, Fisher Martin, Walsh John, Orkin Chloe, Ainsworth Jonathan, Leen Clifford, Sabin Caroline, UK Collaborative HIV Cohort (UK CHIC) Study (Appendix). Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?. The Journal of infectious diseases. 2012. DOI: 10.1093/infdis/jir380.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.